UROGEN PHARMA ($URGN) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of -$0.47 per share, beating estimates of -$0.49 by $0.02. The company also reported revenue of $50,960,000, beating estimates of $45,716,022 by $5,243,978.
You can see Quiver Quantitative's $URGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UROGEN PHARMA Insider Trading Activity
UROGEN PHARMA insiders have traded $URGN stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $URGN stock by insiders over the last 6 months:
- MARK SCHOENBERG (Chief Medical Officer) has made 0 purchases and 4 sales selling 17,373 shares for an estimated $395,174.
- JASON DREW SMITH (General Counsel) has made 0 purchases and 3 sales selling 7,479 shares for an estimated $147,261.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
UROGEN PHARMA Hedge Fund Activity
We have seen 82 institutional investors add shares of UROGEN PHARMA stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TORONTO DOMINION BANK removed 3,190,510 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $74,721,744
- AMERICAN CENTURY COMPANIES INC added 1,358,812 shares (+inf%) to their portfolio in Q4 2025, for an estimated $31,823,377
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 1,125,100 shares (+inf%) to their portfolio in Q4 2025, for an estimated $26,349,842
- MILLENNIUM MANAGEMENT LLC removed 849,785 shares (-57.9%) from their portfolio in Q4 2025, for an estimated $19,901,964
- MPM BIOIMPACT LLC added 806,378 shares (+597.3%) to their portfolio in Q4 2025, for an estimated $18,885,372
- FRONTIER CAPITAL MANAGEMENT CO LLC added 781,620 shares (+inf%) to their portfolio in Q4 2025, for an estimated $18,305,540
- TANG CAPITAL MANAGEMENT LLC removed 650,000 shares (-65.0%) from their portfolio in Q4 2025, for an estimated $15,223,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
UROGEN PHARMA Government Contracts
We have seen $135,108 of award payments to $URGN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- JELMYTO KIT - ANTINEOPLASTIC ANTIBIOTICS: $102,264
- ZUSDURI MEDICATION: $32,844
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
